Freyr Supported a U.S.-Based Core Therapeutic Pharmaceutical Company with Korean Medical Literature Monitoring and Regulatory Intelligence

Client Overview

A U.S.-based pharmaceutical company operating in core therapeutic areas required ongoing support to monitor Korean medical literature and stay informed of local Regulatory developments relevant to its operations in South Korea.

Background

The client needed a reliable mechanism to monitor Korean-language medical journals and track region-specific Regulatory developments. Due to language barriers and the need for timely Regulatory insights, the client sought a structured solution that would provide regular updates in both Korean and English while supporting compliance with South Korea's Ministry of Food and Drug Safety (MFDS) expectations.

Services in Scope

Korean medical literature monitoring from credible

journal sources

Regulatory intelligence support

Weekly bilingual (Korean and English) reporting

Monitoring of region-specific medical and Regulatory developments

Translation and summarization of relevant literature findings

Challenge

The client faced significant challenges in accessing and navigating Korean-language medical journal platforms, as many of the available search tools and resources were only accessible in Korean.

This language barrier made it difficult to consistently identify and monitor relevant medical literature.

In addition, the client required regular tracking of Korean medical publications and evolving Regulatory developments to support informed decision-making and maintain compliance with South Korean requirements.

The need for accurate bilingual information in both Korean and English further complicated the process, while the absence of a reliable and structured literature monitoring system created inefficiencies and increased the risk of missing critical scientific and Regulatory updates.

Solution

Freyr implemented a structured Korean medical literature monitoring and Regulatory intelligence program tailored to the client’s therapeutic areas and compliance needs.

The team conducted comprehensive searches across credible Korean medical journal websites to identify and track relevant scientific publications and emerging developments.

To overcome language barriers and facilitate informed decision-making, Freyr prepared and delivered concise weekly reports summarizing key findings in both Korean and English.

In addition, ongoing monitoring of Regulatory developments and industry updates ensured that the client remained informed of changes relevant to its operations in South Korea.

By establishing a reliable and systematic monitoring process, Freyr enabled continuous access to critical medical and Regulatory information while improving the efficiency and consistency of information flow.

Impact

Through its structured medical literature monitoring and Regulatory intelligence support, Freyr enabled the client to stay informed of critical scientific and Regulatory developments in South Korea while reducing the operational burden associated with manual monitoring activities. The engagement improved information accessibility, strengthened compliance readiness, and supported more efficient decision-making across the client's Regulatory functions.